logo
How Do You Treat Type 1 Diabetes?

How Do You Treat Type 1 Diabetes?

Health Line12-06-2025
Managing type 1 diabetes means you'll have to take insulin each day. You may also work with a doctor to treat T1D with other medications in addition to insulin, and determine what else may be best for your diabetes care goals.
Treating type 1 diabetes (T1D) is not as simple as just taking a particular medication or using a therapy, but it's more of a management puzzle that has many different parts.
People with T1D must take insulin because their bodies do not naturally produce it. This is a required and first-line treatment for anyone with this autoimmune condition.
Beyond that, people with T1D may also take other medications and use different methods to help manage their blood sugar levels. This is where your healthcare team plays a key role in helping to create a diabetes management plan and how to best treat your T1D based on many factors.
Managing type 1 diabetes
While the 'treatment' for a chronic condition is often viewed through the lens of medications or other therapies, T1D is one of those that requires constant management and affects how certain medications work.
That is why treating T1D goes beyond just insulin and medication use. Diabetes management involves monitoring blood sugar levels, keeping track of what you consume each day, maintaining enough physical activity, managing your mental health, and more.
Using insulin
People with T1D must take insulin each day.
Their bodies don't naturally make insulin, so it must be administered in another way.
Many different types of insulin exist, ranging from fast short-acting insulin taken each time you eat or consume carbohydrates to longer-acting insulin that lasts in your body for hours at a time.
Whatever type of insulin you take, you administer it through injections with a syringe or prefilled insulin pen. Others may choose to use an insulin pump device to administer their insulin each day.
Insulin pens
Many different types of insulin pens exist for long-acting and mealtime insulin forms. You may find these differ slightly based on the insulin you're using.
Many of the most common insulin pens are disposable. They contain a prefilled cartridge that can be used for a certain number of days, and when the cartridge is empty, the entire pen is thrown away.
Some reusable pens are also available, allowing you to replace the insulin cartridge when it's empty.
The needles on insulin pens are known as pen needles, and they come in different lengths and thicknesses based on your preferences.
Insulin pumps
Insulin pumps are wearable devices that people with diabetes use to deliver insulin. They are connected to a spot on your body and continuously give insulin for 2 to 4 days.
These devices deliver a programmed amount of insulin through a small tube called a cannula, inserted just under the top layer of your skin. Your doctor will work with you to determine how much insulin you need each day.
Insulin pumps can also deliver an insulin bolus, which is an extra dose of insulin in addition to your basal rate.
Some pumps may automatically give you boluses based on your higher blood sugar or carbs, but most allow you to enter a manual bolus for the pump to deliver when needed.
Historically, insulin pumps were completely manual devices that you had to program for any insulin. In more recent years, advanced technology now available allows for algorithms to calculate and automatically deliver if you use the device with a connected CGM.
Off-label medications for type 1 diabetes
Other diabetes medications may also be something to discuss with your doctor. These may include Metformin, GLP-1s, or SGLT-2s meds, which aren't cleared by regulators to use with T1D but may be beneficial beyond that labeling.
While some research does show the benefit of these medications for T1D, it indicates there may not be a significant blood sugar improvement, and there may be a high risk of increased hypoglycemia, hyperglycemia, and DKA.
That is why it's always important to consult a doctor and your diabetes care team to discuss possible pros and cons if you're interested in using an off-label treatment for T1D along with insulin. It's also important to take all medications as prescribed.
Metformin
Metformin is a type of oral medication that's approved for type 2 diabetes. However, it's now also commonly prescribed by doctors, and some people with T1Ds use them successfully along with their insulin.
Since some T1Ds can develop insulin resistance, the insulin they take each day may not work as well as it once did. Metformin may be an option because it helps reduce sugar production in the liver.
Your doctor may advise you to take Metformin in addition to insulin, but that could mean they'd have to write an off-label prescription.
GLP-1s
Glucagon-like peptide-1 receptor (GLP-1) agonists help manage blood sugar levels and reduce hunger and food intake, possibly supporting weight loss along with managing diabetes glucose levels.
These may include:
Ozempic
Wegovy
Trulicity
Victoza
While these are FDA-cleared for those with T2D, some people with type 1 diabetes also choose to use these for the same reasons.
The diabetes clinical community, along with T1Ds, has been advocating for the FDA to consider labeling these medications beyond just T2D use, but as of mid-2025, that hasn't yet materialized.
SGLT-2 inhibitors
Sodium-glucose transport protein 2 (SGLT2) inhibitors are a class of medications that are also known as gliflozins. These prevent glucose from reabsorbing after it's filtered through your kidneys, helping that glucose to leave your body through urine and lowering blood sugar levels.
Invokana
Jardiance
Farxiga
Steglatro
This 2023 research review found moderate benefits for SGLT-2s in people type 1 diabetes, without an increase in risk or side effects.
One specific SGLT-2 called Sotagliflozin (Zynquista) could eventually be used to treat T1D along with insulin. It would work to lower glucose levels by forcing the body to release it in urine and reducing glucose absorption in the gut.
This 2019 research review shows the promise of the medication being used for T1D. However, the Food and Drug Administration (FDA) denied Sotagliflozin in both 2019 and 2024 due to some concerns about the medication.
However, it is approved by the European Medicines Agency (EMA) and may be reconsidered by the FDA in the future.
Consult your diabetes care team
Managing and treating type 1 diabetes is a very individualized process that requires working with your healthcare team. They can best help you understand the condition and learn what treatments may be best for your personal diabetes management and health goals.
Always consult your care team before making any treatment decisions, including the types and dosages of any medications you take.
For people with T1D, this will likely include diabetes specialists, including an endocrinologist, diabetes care and education specialist, and nutritionist or dietitian.
Cure research and related treatments
While there isn't a T1D cure on the horizon, researchers continue studying ways to prevent this autoimmune condition and reverse it for those who've already been diagnosed.
Some of the more promising research avenues currently include:
Gene therapy
For T1D, gene therapy could involve reprogramming alternative cells, making those reprogrammed cells perform the functions of the original insulin-producing beta cells.
But the reprogrammed cells would be different enough from beta cells so that your own immune system wouldn't recognize them as 'new cells' and attack them, which is what happens in the development of T1D.
Islet cell transplants
This involves transplanting donated or newly created insulin-making islet cells into the body or pancreas of someone with T1D. Islet transplants aren't new and have been an experimental treatment for many years.
This requires immunosuppressant drugs, which often have other side effects and are more expensive. Despite the limited promise of this therapy, many challenges exist.
In 2023, the FDA approved a first-of-its-kind treatment for a small number of people with T1D who have severe hypoglycemia and struggle to maintain their blood sugars. Known as Lantrida, this is the first pancreatic islet cellular therapy made from deceased donor pancreatic cells.
Other ongoing research explores using stem cells to generate new islet cells rather than transplanting them.
Functional bionic therapy
Largely based on technology that includes insulin pumps and continuous glucose monitors (CGM), these options to treat and manage T1D may be considered a 'functional cure' —something that basically makes life with this type of diabetes minimally burdensome and almost as 'good as being cured' for some people.
These may be the evolving technologies, including closed-loop systems that automatically manage insulin and glucose monitoring to keep blood sugars in target range. Various early systems exist and are getting better, and some believe that this could eventually become a standard of care in managing T1D — assuming affordability and access allow for it.
The takeaway
Insulin is the main and only required treatment for type 1 diabetes. This is needed because people with T1D don't naturally make insulin in their bodies as those without the condition do.
Other medications and types of therapy, alongside insulin, may also help people manage their blood sugar levels and diabetes overall. Some of these prescription medications may be considered 'off-label' drugs if your doctor is willing to prescribe them for T1D.
Diabetes management means routine blood sugar monitoring, exercise and eating routines, and other aspects, from sleep to mental health.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Texas A&M mascot Reveille has eye removed after glaucoma diagnosis
Texas A&M mascot Reveille has eye removed after glaucoma diagnosis

Yahoo

time22 minutes ago

  • Yahoo

Texas A&M mascot Reveille has eye removed after glaucoma diagnosis

Texas A&M announced Wednesday that Reveille X, the school's mascot, had to have an eye removed during surgery after she was diagnosed with glaucoma. The collie has served as A&M's mascot since April 30, 2021, when Reveille IX retired. Reveille is a central part of gameday activities at Texas A&M and runs out on the field ahead of home games before taking her normal spot on the sidelines. 'Under the watchful eye of her Mascot Corporals, it came to our attention that Miss Rev has been experiencing some discomfort and cloudiness in her right eye,' A&M president Mark Welsh said in a statement. Sadly, the issue has progressed and during a recent check-up, she was diagnosed with glaucoma. At the recommendation of our world-class veterinarians at the Texas A&M Veterinary Medical Teaching Hospital, Miss Rev underwent surgery earlier [Wednesday] to relieve any discomfort. During surgery, the veterinary team discovered signs of abnormal tissue, and out of an abundance of caution, removed her eye. The tissue was sent to an ocular pathologist for evaluation, which is standard practice.' Welsh said in his statement that Reveille would not make any public appearances while she recovers from her surgery, but that the school 'can expect Miss Rev to be back to enjoying all her favorite activities — cruising on Rev Force One, attending classes, cheering on the Aggies, and keeping our campus squirrels in line - this fall.' The first Reveille was adopted by A&M students in the 1930s and the mascot is officially listed as the highest-ranking member of school's Corps of Cadets. Members of the corps take care of Reveille and she goes everywhere with her caretakers and she's the only non-service dog allowed on campus building. According to Texas A&M tradition, if Reveille barks during a class she's in, the class is canceled.

Kennedy Rescinds Endorsements for Some Flu Vaccines
Kennedy Rescinds Endorsements for Some Flu Vaccines

New York Times

time23 minutes ago

  • New York Times

Kennedy Rescinds Endorsements for Some Flu Vaccines

Health Secretary Robert F. Kennedy Jr. on Tuesday formally rescinded federal recommendations for all flu vaccines containing thimerosal, a mercury-based preservative that the anti-vaccine movement has falsely linked to autism. The decision cements a move last month by vaccine advisers whom Mr. Kennedy named to the federal Advisory Committee on Immunization Practices after abruptly firing all 17 previous members. After hearing a presentation by the former leader of an anti-vaccine group, the panel had voted to walk back federal recommendations for all flu vaccines containing thimerosal. The decision will not affect most Americans seeking flu vaccines: Thimerosal is added to multidose vials of flu vaccines to prevent bacteria from growing, but it is not an ingredient of the single-dose vials administered to most people. During the 2024-25 respiratory virus season, only 3 percent of children and 2 percent of older adults received flu vaccines containing thimerosal, according to an analysis of electronic health records by Truveta, a company that analyzes such records. Still, multidose vials are needed in places where it is difficult to store many vaccines, such as nursing homes or mobile clinics serving remote rural areas. Mr. Kennedy's sign-off does not withdraw vaccines containing thimerosal from the market. But his rescinding the federal recommendation means that such shots may not be available to Americans, because insurance companies are no longer required to cover them. 'We urge global health authorities to follow this prudent example for the protection of children worldwide,' Mr. Kennedy said in a statement. Vaccine manufacturers have confirmed that they have the capacity to replace multidose vials containing mercury, ensuring that vaccine supplies for children and adults will 'remain uninterrupted,' the Department for Health and Human Services said in a statement. Federal health officials began removing thimerosal from childhood vaccines about 25 years ago, citing an abundance of caution despite a lack of data supporting safety concerns. Dozens of studies have shown thimerosal to be harmless. But the anti-vaccine community has long falsely maintained that the ingredient can cause neurological problems. At a meeting of the vaccine advisers last month, Lyn Redwood, a former leader of Children's Health Defense, the anti-vaccine group founded by Mr. Kennedy, claimed thimerosal was dangerous and toxic to children. Her presentation incorrectly said the only flu vaccine still containing thimerosal had 50 micrograms per dose, double the actual amount. The seven new advisers voted 5-1, with one abstention, to withdraw recommendations for flu vaccines containing thimerosal for children, pregnant women and other adults. The director of the Centers for Disease Control and Prevention typically accepts the recommendations of the committee. But the agency does not currently have a leader, and so the decision fell to Mr. Kennedy.

Powering Possibilities In Healthcare With AI And Edge Computing
Powering Possibilities In Healthcare With AI And Edge Computing

Forbes

time24 minutes ago

  • Forbes

Powering Possibilities In Healthcare With AI And Edge Computing

Imagine a hospital where a clinician can receive critical diagnostic insights in real-time, patient care isn't hindered by geography or resource limitations, and administration is so frictionless that clinicians can focus entirely on their patients. This is not a distant dream; this is what AI and edge computing are enabling right now. The intersection of AI and edge computing is empowering providers to make faster, better decisions that improve lives. The healthcare industry generates staggering amounts of data daily, from electronic health records, real-time monitoring devices used in ICU wards, even telemetry data recorded on smart watches. The real challenge is healthcare organizations are drowning in data, but are thirsty for knowledge, and this is where AI and edge computing can make a difference. By processing data close to where it's generated, edge computing drives real-time performance, provides better access and enhances security, essential in healthcare. Combine this with AI's ability to analyze data at blistering speeds, and you get insights that improve clinical decision-making and operational choices. Predictive analytics, for instance, empower hospitals to anticipate patient surges, optimize staffing schedules, and even ensure that life-saving supplies are available when needed. Take diagnostic imaging as another example. AI-enhanced imaging tools can identify conditions such as tumors or cardiovascular abnormalities with remarkable accuracy. These tools often provide access to and enhance specialists' capacity to serve in remote settings, delivering life-saving information directly at the point of care. Personalized medicine is one of the most exciting advancements in healthcare today. By leveraging tools like the Dell AI Factory with NVIDIA, healthcare providers can implement sophisticated AI models to tailor care to the unique needs of each individual. A patient's genetic profile, combined with their medical history and lifestyle data, allows clinicians to craft treatment plans and predictive diagnostics never before possible. This approach is already transforming oncology care, where genomic analysis guides targeted therapies. Tools within this ecosystem can identify complications before they escalate, paving the way for preemptive care. And the benefits extend beyond clinical walls. Edge computing makes it possible to bridge care gaps in underserved areas, connecting patients to specialists via digital health solutions and delivering remote care. Picture a rural patient managing their chronic condition with AI-driven devices that continuously monitor their health and alert medical professionals when intervention is needed. With these tools, care becomes inclusive, accessible, and proactive. A great example of how technology drives healthcare transformation is the Guthrie Clinic. Serving a sprawling region, Guthrie implemented the Dell AI Factory with NVIDIA within its operations to great effect. One remarkable outcome was its success in reducing patient falls by 70%. Using AI-driven computer vision, the clinic tracks patient movement patterns and identifies potential fall risks. When a risk is detected, the system alerts healthcare teams, enabling immediate intervention. This proactive approach ensures patient safety and fosters trust between caregivers and those they serve. The efficiencies don't stop there. By equipping clinical teams with time-saving tools, the Guthrie Clinic improved discharge speeds, reduced readmissions and created capacity to accept 85% of hospital transfer requests. AI didn't just enhance operations, it improved quality care, making care more accessible to every patient. Watch the video to learn more about Guthrie Clinic's transformational story. While patient care is at the heart of healthcare, smooth operations are essential for providers and systems to deliver outcomes. AI and edge computing are key to achieving this balance. From optimizing workflows to forecasting resource needs, these tools allow healthcare systems to function with agility and precision. For example, predictive models powered by AI anticipate ICU occupancy rates, ensuring vital equipment and staff are ready when needed. Additionally, digital twin technologies simulate emergency scenarios, preparing clinical teams for real-world challenges with confidence. Dell NativeEdge amplifies these capabilities by simplifying deployment processes. Through intuitive, zero-touch solutions, healthcare organizations can integrate AI without disruption, scaling critical functions as demands evolve. It's technology working seamlessly behind the scenes, enabling caregivers to focus entirely on patients. The integration of AI and edge computing isn't just solving today's problems, it's redefining the future of healthcare to create a reality where chronic illnesses are anticipated before they develop, operating rooms are enhanced with real-time data, and healthcare reaches patients wherever they are, without barriers. At the forefront of this transformation, Dell Technologies and NVIDIA are working together to elevate healthcare systems globally. By leveraging tools like edge computing and AI, they're helping organizations create inclusive, resilient systems that prioritize patient outcomes above all else. The future of healthcare is extraordinary, and it's happening now. Whether you're exploring ways to improve operational efficiency, enhance diagnostic precision, or personalize care, AI and edge computing hold the solutions you need. Solutions like the Dell AI Factory with NVIDIA empower healthcare providers to achieve smarter operations, better outcomes, and, ultimately, change lives. Are you ready to be part of this transformation? Download the eBook, Transforming Healthcare and Life Sciences with AI and Edge Computing, to discover actionable strategies and learn how technology can empower your care delivery. Together, we can drive progress and reimagine what's possible in healthcare.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store